The National Institute of Dental and Craniofacial Research awarded a purchase order to Cellink LLC for $39,500 on September 4, 2020, under a total small business set-aside. Performance occurs in Blacksburg, Virginia. The order procures advanced biomedical research equipment supporting the Cell Biology Section's investigation of cell interactions and three-dimensional cell migration. The purchase order is firm fixed price with an ultimate completion date of December 3, 2020. The solicitation...
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $48,544.00 on August 7, 2026, with an ultimate completion date of August 6, 2027. The order is firm fixed price with no set-aside applied. Work is performed in Carlsbad, California. The purchase order procures EVOS M7000 laboratory imaging equipment.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>
<p>The National Cancer Institute awarded a purchase order to Cellomics Technology LLC for $17,110.00 on March 4, 2020. The order covers lab testing services. Work is performed in Halethorpe, Maryland. The order has a firm fixed price structure and an ultimate completion date of July 4, 2020.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,621.46 on November 20, 2019, with an ultimate completion date of December 19, 2019. The order procures drugs and biologicals on a firm fixed-price basis. Place of performance is Grand Island, New York.</p>
<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $22,130 in lab equipment on June 9, 2021, with completion by July 9, 2021. The award carries no small business set-aside. Performance is in Carlsbad, California. The order is firm fixed price and was issued to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability.</p>
<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for ION 540 chip kits at $13,504.05 on April 2, 2019, with completion due May 2, 2019. Performance occurs at the vendor's Carlsbad, California facility. The order is firm fixed price with no small business set-aside.</p>